BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Nonfunding) Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017

Contacted: Treasury, Dept of; Internal Revenue Service (IRS); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR)

Consumer Issues/Safety/Products CSP

Genetically Engineered (GE) Animals --Amendment on GE Salmon Labeling --Amendment to Restrict FDA Approval of GE Salmon --Labeling --One Health Legislation (Senate Discussion Draft) --FDA Approval --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Review and Labeling of Food Derived From Biotechnology --H.R. 1599: Safe and Accurate Food Labeling Act of 2015 --S.2609: The Biotech Labeling Solutions Act --U.S. Government Policy USDA/APHIS Agricultural Biotechnology Regulations --Efficient Science-Based Review of Biotech Products --USDA Decision on GE Crops Environmental Impact Statement --Co-existence of Production Systems --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Biosimilars --Implementation of Affordable Care Act --Interchangeability and Pharmacy Substitution --Naming --Brazil Biologics Regulations Drug Importation --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017

Contacted: Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Medicare Payment Advisory Commission (MedPAC); Agriculture, Dept of (USDA); SENATE; Internal Revenue Service (IRS); U.S. Trade Representative (USTR); Treasury, Dept of; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: S. 2609 (114th), H.R. 1599 (114th)

Trade (domestic/foreign) TRD

TransPacific Partnership --Data and Intellectual Property Protection for Pharmaceuticals --Reimbursement Transparency Foreign Agricultural Biotechnology Laws and Regulations --Asynchrony of International Approvals --China Biotechnology Regulations --EU Ag-Biotech Policies and Regulations --Korea Biotechnology Regulations --Like-minded Countries Initiatives Biosimilars --Brazil Biologics Regulations Drug Importation --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Pacific Alliance IP Harmonization Transatlantic Trade and Investment Partnership --Ag-Biotech Issues UN Commission on Access to Medicines

Contacted: Commerce, Dept of (DOC); SENATE; Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Internal Revenue Service (IRS); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS)

Agriculture AGR

EPA Regulations on Biotechnology --Reauthorization of Pesticide Registration Improvement Act (PRIA) --EPA Points to Consider Guidance Document for GE Algae Review of the Federal Coordinated Framework for Biotechnology Products USDA/APHIS Agricultural Biotechnology Regulations --Efficient Science-Based Review of Biotech Products --USDA Decision on GE Crops Environmental Impact Statement --Co-existence of Production Systems --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Foreign Agricultural Biotechnology Laws and Regulations --EU Ag-Biotech Policies and Regulations --China Biotechnology Regulations --Asynchrony of International Approvals --Like-minded Countries Initiatives --Korea Biotechnology Regulations Review and Labeling of Food Derived From Biotechnology --H.R. 1599: Safe and Accurate Food Labeling Act of 2015 --U.S. Government Policy --S.2609: The Biotech Labeling Solutions Act Adventitious Presence (Low Level Presence) --International Low Level Presence Policies Funding for the USDA --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Genetically Engineered (GE) Animals --Amendment on GE Salmon Labeling --Amendment to Restrict FDA Approval of GE Salmon --Labeling --One Health Legislation (Senate Discussion Draft) --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 --FDA Approval Funding for Biomass Crop Assistance Program --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 TransAtlantic Trade and Investment Partnership --Ag-Biotech Issues

Contacted: Commerce, Dept of (DOC); Treasury, Dept of; U.S. Trade Representative (USTR); Internal Revenue Service (IRS); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); SENATE; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO)

Bills named: H.R. 1599 (114th), S. 2609 (114th)

Taxation/Internal Revenue Code TAX

Biofuels (Non-Funding) --Production Tax Credit Extension --S. 2658: Federal Aviation Administration Reauthorization Act of 2016 ----Franken-Grassley Amendment Research & Development Tax Credit Reforms --Extension --Permanency --Refundable R&D Credit Capital Formation Investment Incentives --H.R. 2179: PARTNER Act --Reform of Capital Gains Rules --Reform of Net Operating Loss Rules --Reform of Passive Loss Rules --S. 341: Start-up Jobs and Innovation Act --S. 537: COMPETE Act Tax Reform --Innovation Box / Patent Box Orphan Drug Act Tax Credit Antibiotic & Diagnostic Tax Credit --H.R. 3539: Antibiotic & Diagnostic Innovation Act Inversions --Financial Services and General Government Appropriations Act for FY 2017 Renewable Chemicals/Bio-based Products (Non-Funding) --Investment Tax Credit for Renewable Chemicals and Bio-based Products --S. 2271: The Renewable Chemicals Act --S. 1656/H.R. 2883: Master Limited Partnership Parity Act --H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act  

Contacted: Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Treasury, Dept of; SENATE; Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Internal Revenue Service (IRS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2883 (114th), S. 341 (114th), S. 537 (114th), H.R. 3539 (114th), S. 2271 (114th), S. 1656 (114th), H.R. 2179 (114th), S. 2658 (114th), H.R. 3390 (114th)

Copyright/Patent/Trademark CPT

TransPacific Partnership --Data and Intellectual Property Protection for Pharmaceuticals Patent Reform --H.R. 9: Innovation Act --S.1137: The PATENTS Act of 2015 Bayh-Dole Act/Tech Transfer --Commercialization of Federally Funded Research Initiative --March-In Rights Intellectual Property International Enforcement Pacific Alliance IP Harmonization Inter Partes Review --Implementation of the American Invents Act of 2011 --S. 1137: The PATENTS Act of 2015 World Trade Organization - Special 301 Submissions --Middle East Issues --Latin American Issues --Canada Issues UN Commission on Access to Medicines

Contacted: Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); SENATE; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Commerce, Dept of (DOC)

Bills named: S. 1137 (114th), H.R. 9 (114th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals --Amendment on GE Salmon Labeling --Amendment to Restrict FDA Approval of GE Salmon --Labeling --One Health Legislation (Senate Discussion Draft) --FDA Approval --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Review and Labeling of Food Derived From Biotechnology --H.R. 1599: Safe and Accurate Food Labeling Act of 2015 --U.S. Government Policy --S.2609: The Biotech Labeling Solutions Act

Contacted: Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; SENATE; Patent & Trademark Office (PTO); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA)

Bills named: S. 2609 (114th), H.R. 1599 (114th)

Health Issues HCR

Biosimilars --Coding --Implementation of Affordable Care Act --Interchangeability and Pharmacy Substitution --Naming --Patent Certification --Brazil Biologics Regulations Funding for National Institutes of Health --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for Centers for Disease Control and Prevention Vaccine Programs --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 340B Drug Pricing Program --Implementation of Affordable Care Act --Program Implementation & Oversight --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Medicaid Pricing and Rebates --Average Manufacturer Price Calculations --Implementation of Affordable Care Act Drug Importation --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Diagnostics and Personalized Medicine Regulation and Oversight Funding for FDA --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Biodefense Research, Development and Procurement Issues (Nonfunding) Reimbursement for Innovative Products --Medicare Part B Physician-Administered Products --Medicare Part D Prescription Drug Program: ----CMS Proposed Rule on Protected Classes --Value-based Contracting and Communications Drug Evaluation and Review --Compassionate Use/Expanded Access --FDA Proposed Rule on Changes to Drug Labeling --Implementation of the FDA Safety and Innovation Act --Reauthorization of the Prescription Drug User Fee Act --Special Medical Use/Limited Population Drug ---- ADAPT Act (House Discussion Draft) Senate Innovation for Healthier Americans --Biomarkers and Regulatory Science Improvements --Expanded Access to Investigational Drugs --Expedited Pathways --FDA Hiring Flexibility --FDA Management and Financial Accountability --Innovation Incentives --Longitudinal Study of Chronic Diseases --Patient Access to Approved Drugs --Patient-Focused Drug Development --Use of Real-World Evidence --Vaccine and Anti-Microbial Resistance Product Development and Incentives ----S. 195: PATH Act --Communication with Healthcare Professionals and Payors --Priority Review Voucher Programs Priority Review of Generic Drugs ----S. 2615: Increasing Competition in Pharmaceuticals Act Vaccines and Infectious Diseases - General Government Price Reporting --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Gene Editing Technologies --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Precision Medicine Initiative Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Antibiotic & Diagnostic Tax Credit --H.R. 3539: Antibiotic & Diagnostic Innovation Act Drug Manufacturing, Quality & Distribution --Supply Chain Integrity and Traceability Affordable Care Act Implementation --Third Party Support of Patient Premiums and Cost-Sharing Obligations Combating Antibiotic-Resistant Bacteria (CARB) Initiative Vaccine Access/Financing --Adult Immunization (Senate Discussion Draft) --Implementation of Affordable Care Act --Senate Chronic Care Working Group Proposals --Vaccine Injury Compensation Program TransPacific Partnership --Data and Intellectual Property Protection for Pharmaceuticals --Reimbursement Transparency Orphan Drug Act Tax Credit UN Commission on Access to Medicines

Contacted: SENATE; Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC); Treasury, Dept of; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); Food & Drug Administration (FDA); Agriculture, Dept of (USDA)

Bills named: H.R. 3539 (114th), S. 195 (114th), S. 2615 (114th)

Small Business SMB

Sarbanes Oxley Section 404 (b) --PCAOB Audit Cost Increases --H.R. 4139: Fostering Innovation Act XBRL Exemption for Small Public Companies --H.R. 1965: Small Company Disclosure Simplification Act --H.R. 1675: Capital Markets Improvement Act Capital Market Enhancements --H.R. 1675: Encouraging Employee Ownership Act --H.R. 4168: Small Business Capital Formation Enhancement Act --H.R. 3784: Securities & Exchange Commission Small Business Advocate Act --H.R. 1675: Capital Markets Improvement Act --H.R. 2354: Streamlining Excessive and Costly Regulations Review Act --H.R. 4638: Main Street Growth Act Proxy Advisory Services --Impact of Policies on Small Public Companies --Proxy Advisory Firm Reform Act (Discussion Draft) Reform of SEC Regulation D --S. 978/H.R. 4498: HALOS Act Short Selling Transparency Capital Formation Investment Incentives --H.R. 2179: PARTNER Act --Reform of Capital Gains Rules --Reform of Net Operating Loss Rules --Reform of Passive Loss Rules --S. 341: Start-up Jobs and Innovation Act --S. 537: COMPETE Act

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Treasury, Dept of; Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); SENATE; Environmental Protection Agency (EPA); Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Internal Revenue Service (IRS); Patent & Trademark Office (PTO)

Bills named: S. 341 (114th), S. 537 (114th), H.R. 1965 (114th), S. 978 (114th), H.R. 4498 (114th), H.R. 3784 (114th), H.R. 4638 (114th), H.R. 4139 (114th), H.R. 2179 (114th), H.R. 1675 (114th), H.R. 2354 (114th), H.R. 4168 (114th)

Medicare/Medicaid MMM

Medicaid Pricing and Rebates --Average Manufacturer Price Calculations --Implementation of Affordable Care Act Reimbursement for Innovative Products --Medicare Part B Physician-Administered Products --Medicare Part D Prescription Drug Program: ----CMS Proposed Rule on Protected Classes --Value-based Contracting and Communications Government Price Reporting --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Senate Innovation for Healthier Americans --Patient Access to Approved Drugs  

Contacted: SENATE; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Internal Revenue Service (IRS); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Treasury, Dept of; Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA)

Budget/Appropriations BUD

Funding for the USDA --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Funding for Biomass Crop Assistance Program --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Funding for FDA --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for Centers for Disease Control and Prevention Vaccine Programs --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Funding for National Institutes of Health --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for Biofuels --Department of Defense Funding of Advanced Biofuels --Energy and Water Development and Related Agencies Appropriations Act for FY 2017 Funding for Renewable Chemicals/Bio-based Products --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Energy Basic Research Funding --Advanced Research Projects Agency --DOE Office of Science --Energy and Water Development and Related Agencies Appropriations Act for FY 2017

Contacted: U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Internal Revenue Service (IRS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH); Medicare Payment Advisory Commission (MedPAC); Agriculture, Dept of (USDA)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Renewable Chemicals/Bio-based Products (Non-Funding) --Nomenclature Usage --S. 2271: The Renewable Chemicals Act --S. 1656/H.R. 2883: Master Limited Partnership Parity Act --H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act --H.R. 2576: TSCA Modernization Act --S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act --Implementation of the Agricultural Act of 2014 --Reauthorization of USDA Bio-Preferred Program --Investment Tax Credit for Renewable Chemicals and Bio-based Products EPA Regulations on Biotechnology --Reauthorization of Pesticide Registration Improvement Act (PRIA)

Contacted: Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Treasury, Dept of; SENATE

Bills named: S. 1656 (114th), S. 2271 (114th), S. 697 (114th), H.R. 2576 (114th), H.R. 3390 (114th), H.R. 2883 (114th)

Energy/Nuclear ENG

Funding for Renewable Chemicals/Bio-based Products --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 EPA Regulation of Biotechnology --EPA Points to Consider Guidance Document for GE Algae Energy Basic Research Funding --Advanced Research Projects Agency --DOE Office of Science --Energy and Water Development and Related Agencies Appropriations Act for FY 2017 Funding for Biofuels --Department of Defense Funding of Advanced Biofuels --Energy and Water Development and Related Agencies Appropriations Act for FY 2017 Renewable Fuel Standard --The 2014-2016 Final Rule --Departments of Interior, and Related Agencies Appropriations Act for FY 2017 Review of the Federal Coordinated Framework for Biotechnology Products Renewable Chemicals/Bio-based Products (Non-Funding) --Implementation of the Agricultural Act of 2014 --Investment Tax Credit for Renewable Chemicals and Bio-based Products --Nomenclature Usage --Reauthorization of USDA Bio-Preferred Program --S. 2271: The Renewable Chemicals Act --S. 1656/H.R. 2883: Master Limited Partnership Parity Act --H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act --H.R. 2576: TSCA Modernization Act --S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act Biofuels (Non-Funding) --Production Tax Credit Extension --S. 1239/H.R. 1736: to amend the Clean Air Act with respect to the ethanol waiver for the Reid vapor pressure limitations under that Act --S. 2658: Federal Aviation Administration Reauthorization Act of 2016 ----Franken-Grassley Amendment Funding for Biomass Crop Assistance Program --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017

Contacted: Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Treasury, Dept of; Internal Revenue Service (IRS); Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA)

Bills named: H.R. 2576 (114th), S. 2271 (114th), S. 1239 (114th), H.R. 2883 (114th), H.R. 1736 (114th), S. 697 (114th), S. 2658 (114th), S. 1656 (114th), H.R. 3390 (114th)

Animals ANI

Genetically Engineered (GE) Animals --Amendment on GE Salmon Labeling --Amendment to Restrict FDA Approval of GE Salmon --Labeling --One Health Legislation (Senate Discussion Draft) --FDA Approval --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Medicare Payment Advisory Commission (MedPAC); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Treasury, Dept of; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); SENATE

Fuel/Gas/Oil FUE

Funding for Renewable Chemicals/Bio-based Products --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 EPA Regulation of Biotechnology --EPA Points to Consider Guidance Document for GE Algae Energy Basic Research Funding --Advanced Research Projects Agency --DOE Office of Science --Energy and Water Development and Related Agencies Appropriations Act for FY 2017 Funding for Biofuels --Department of Defense Funding of Advanced Biofuels --Energy and Water Development and Related Agencies Appropriations Act for FY 2017 Renewable Fuel Standard --The 2014-2016 Final Rule --Departments of Interior, and Related Agencies Appropriations Act for FY 2017 Review of the Federal Coordinated Framework for Biotechnology Products Renewable Chemicals/Bio-based Products (Non-Funding) --Implementation of the Agricultural Act of 2014 --Investment Tax Credit for Renewable Chemicals and Bio-based Products --Nomenclature Usage --Reauthorization of USDA Bio-Preferred Program --S. 2271: The Renewable Chemicals Act --S. 1656/H.R. 2883: Master Limited Partnership Parity Act --H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act --H.R. 2576: TSCA Modernization Act --S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act Biofuels (Non-Funding) --Production Tax Credit Extension --S. 1239/H.R. 1736: to amend the Clean Air Act with respect to the ethanol waiver for the Reid vapor pressure limitations under that Act --S. 2658: Federal Aviation Administration Reauthorization Act of 2016 ----Franken-Grassley Amendment Funding for Biomass Crop Assistance Program --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017

Contacted: Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Medicare Payment Advisory Commission (MedPAC); Internal Revenue Service (IRS); SENATE; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Food & Drug Administration (FDA)

Bills named: H.R. 2576 (114th), S. 697 (114th), S. 2271 (114th), H.R. 3390 (114th), S. 1239 (114th), S. 2658 (114th), S. 1656 (114th), H.R. 2883 (114th), H.R. 1736 (114th)

Medical/Disease Research/Clinical Labs MED

Funding for National Institutes of Health --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Biodefense Research, Development and Procurement Issues Senate Innovation for Healthier Americans --Longitudinal Study of Chronic Diseases Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Gene Editing Technologies --Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Precision Medicine Initiative Combating Antibiotic-Resistant Bacteria (CARB) Initiative

Contacted: U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); SENATE; Internal Revenue Service (IRS); Medicare Payment Advisory Commission (MedPAC); Treasury, Dept of; Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES